A jury rules that Masimo’s smartwatch infringes Apple’s design patents.

Apple and medical device company Masimo are currently embroiled in multiple legal battles, most notably over the Apple Watch’s blood oxygen sensor.

But in another case, Apple was handed a victory today courtesy of a Delaware jury. A jury reportedly ruled that two of Masimo’s smartwatches and chargers “intentionally infringed Apple’s patent rights in smartwatch design.” Reuters.

Apple previously accused Masimo of using the lawsuit to promote the launch of its smartwatch products. In October 2022, Apple filed two patent infringement lawsuits against Masimo. The first lawsuit accused Masimo of copying the Apple Watch’s design. The second said Masimo’s technical features infringe on Apple’s patents covering technology used in the Apple Watch.

Reuters Report:

Apple on Friday convinced a federal jury that health monitoring technology company Masimo’s smartwatch infringes two of its design patents.

A Delaware jury agrees with Apple, ruling that Masimo’s W1 and Freedom watches and chargers knowingly infringed Apple’s patent rights in smartwatch design, and sentenced the tech giant to 250 U.S. dollars. ordered to pay damages in the amount of $. Apple’s lawyers told the court that the “ultimate goal” of the lawsuit is to obtain an injunction to stop Masimo from selling its smartwatches following the infringement ruling.

But the jury also found that Masimo’s smartwatch “does not infringe Apple’s patent covering smartwatch inventions, which the tech giant accused Masimo of copying.”

in a statement to 9to5 macApple said the jury’s decision found that Masimo “copied the Apple Watch” and infringed its intellectual property.

“We appreciate the jury’s careful consideration in this case, finding that Masimo knowingly infringed Apple’s patented designs. After years of work on the Watch, Masimo used shortcuts to launch a device that copied the Apple Watch and infringed on our intellectual property. We are pleased to protect the innovations we are making.”

Masimo argued that the jury’s verdict was a victory because Apple was unable to obtain an injunction. “Apple primarily seeks an injunction against Masimo’s current products, and the jury’s verdict is a victory for Masimo on this issue,” the company said in a statement.

Citing the strength of the evidence, Apple said it will continue to consider all options to protect its patented innovations.

Again, this lawsuit does not affect the ongoing legal dispute between Apple and Masimo regarding the Apple Watch’s blood oxygen sensor. Apple CEO Tim Cook said in February that Apple was focused on appealing the ITC’s ruling in the case, rather than settling with the company.

follow chance: thread, TwitterInstagram, and Mastodon.